Comment
European Pharma 2015: Fresh Fields or Deeper into the Mire?
The rhythms of the European Union are very particular — with a new commission and a new parliament every five years and its six-monthly rotation of the presidency of the council of ministers. But at the start of 2015, even the asynchronous EU is sharing some of those vague stirrings of hope for the coming twelve months... Read more |
Global
Cuba: An Untapped Market?
If you're like us at PharmExec, you've been reading the news of potentially thawing US/Cuban relations, and you're wondering, how long before the flag of Cuba graces the Hall of nations at BIO International Convention?... Read more
|
Profile
Sanofi's Big Bet on Integrated Patient Care
Pharm Exec profiles Sanofi's recent hire, EVP Pascale Witz, who is tasked with helping to move a lumbering biopharma giant closer to the embrace of the patient perspective in healthcare... Read more
|
Europe
EU Strengthens Transatlantic Ties
The EU’s extensive transatlantic links have reached a further level of maturity with the completion at the end of 2014 of exchanges between the European Medicines Agency and Health Canada. These exchanges come on top of existing regular sharing of information between the two agencies and interactions through topic-based expert ‘clusters’—notably, recently, on orphan drugs and labelling .... Read more
|
Forecast
Pharm Exec's 2015 Industry Outlook
Pharm Exec's annual report highlights the key scientific, commercial, and reputational trends shaping the industry in the year ahead .... Read more
|
|
|
| //Oryzon Genomics SA (Cambridge, MA, USA and Barcelona, Spain) appointed Gregory L. Weaver as Executive Vice President and Chief Financial Officer, effective January 12, 2015.//Heptares Therapeutics (London, UK and Boston, MA, USA) announced the appointments of Atul Pande and Roberto Solari to its Board of Directors.//Mission Therapeutics (Cambridge, UK) named Dr. Anker Lundemose, MD, Ph.D, as Chief Executive Officer.//uniQure (Amsterdam, The Netherlands) recruited Matthew Kapusta as Chief Financial Officer.//Marken (Research Triangle Park, NC, USA) announced the appointment of Antonio Beloto as General Manager for Argentina and Brazil.// |
|
|
|
